Endocytic iron trafficking and mitochondria in Parkinson's disease

Silvia Cerri, Chiara Milanese, Pier G Mastroberardino

Research output: Contribution to journalArticle

Abstract

Parkinson's disease (PD) - the second most common neurodegenerative disorder - is a multifactorial disease, the causes of which should be sought in complex and detrimental interactions between genetic and environmental factors. Multiple lines of evidence, however, identify mitochondrial dysfunction, oxidative stress, and iron accumulation as central pathogenic mechanisms. These factors are closely intertwined because mitochondria are a major source of pro-oxidant species and are the major intracellular recipients of iron. How iron is transported to mitochondria, however, is largely unknown. Some studies suggest that trafficking through endocytosis may participate to mitochondrial iron delivery with a "kiss and run" mechanism. Intracellular transferrin levels increase in PD, possibly as a consequence of oxidation of iron-containing prosthetic groups in mitochondria. It is therefore conceivable that transferrin endocytic trafficking can contribute to noxious iron accumulation. This short review will summarize these findings and discuss their relevance for a better understanding of PD pathogenesis.

Original languageEnglish
Pages (from-to)70-74
Number of pages5
JournalInternational Journal of Biochemistry and Cell Biology
Volume110
DOIs
Publication statusPublished - Feb 25 2019

Fingerprint

Mitochondria
Parkinson Disease
Iron
Transferrin
Oxidative stress
Endocytosis
Prosthetics
Neurodegenerative Diseases
Reactive Oxygen Species
Oxidative Stress
Oxidation

Cite this

Endocytic iron trafficking and mitochondria in Parkinson's disease. / Cerri, Silvia; Milanese, Chiara; Mastroberardino, Pier G.

In: International Journal of Biochemistry and Cell Biology, Vol. 110, 25.02.2019, p. 70-74.

Research output: Contribution to journalArticle

@article{a8e3da79e5394049b312c6da2fc1d3d1,
title = "Endocytic iron trafficking and mitochondria in Parkinson's disease",
abstract = "Parkinson's disease (PD) - the second most common neurodegenerative disorder - is a multifactorial disease, the causes of which should be sought in complex and detrimental interactions between genetic and environmental factors. Multiple lines of evidence, however, identify mitochondrial dysfunction, oxidative stress, and iron accumulation as central pathogenic mechanisms. These factors are closely intertwined because mitochondria are a major source of pro-oxidant species and are the major intracellular recipients of iron. How iron is transported to mitochondria, however, is largely unknown. Some studies suggest that trafficking through endocytosis may participate to mitochondrial iron delivery with a {"}kiss and run{"} mechanism. Intracellular transferrin levels increase in PD, possibly as a consequence of oxidation of iron-containing prosthetic groups in mitochondria. It is therefore conceivable that transferrin endocytic trafficking can contribute to noxious iron accumulation. This short review will summarize these findings and discuss their relevance for a better understanding of PD pathogenesis.",
author = "Silvia Cerri and Chiara Milanese and Mastroberardino, {Pier G}",
note = "Copyright {\circledC} 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.",
year = "2019",
month = "2",
day = "25",
doi = "10.1016/j.biocel.2019.02.009",
language = "English",
volume = "110",
pages = "70--74",
journal = "International Journal of Biochemistry and Cell Biology",
issn = "1357-2725",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Endocytic iron trafficking and mitochondria in Parkinson's disease

AU - Cerri, Silvia

AU - Milanese, Chiara

AU - Mastroberardino, Pier G

N1 - Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

PY - 2019/2/25

Y1 - 2019/2/25

N2 - Parkinson's disease (PD) - the second most common neurodegenerative disorder - is a multifactorial disease, the causes of which should be sought in complex and detrimental interactions between genetic and environmental factors. Multiple lines of evidence, however, identify mitochondrial dysfunction, oxidative stress, and iron accumulation as central pathogenic mechanisms. These factors are closely intertwined because mitochondria are a major source of pro-oxidant species and are the major intracellular recipients of iron. How iron is transported to mitochondria, however, is largely unknown. Some studies suggest that trafficking through endocytosis may participate to mitochondrial iron delivery with a "kiss and run" mechanism. Intracellular transferrin levels increase in PD, possibly as a consequence of oxidation of iron-containing prosthetic groups in mitochondria. It is therefore conceivable that transferrin endocytic trafficking can contribute to noxious iron accumulation. This short review will summarize these findings and discuss their relevance for a better understanding of PD pathogenesis.

AB - Parkinson's disease (PD) - the second most common neurodegenerative disorder - is a multifactorial disease, the causes of which should be sought in complex and detrimental interactions between genetic and environmental factors. Multiple lines of evidence, however, identify mitochondrial dysfunction, oxidative stress, and iron accumulation as central pathogenic mechanisms. These factors are closely intertwined because mitochondria are a major source of pro-oxidant species and are the major intracellular recipients of iron. How iron is transported to mitochondria, however, is largely unknown. Some studies suggest that trafficking through endocytosis may participate to mitochondrial iron delivery with a "kiss and run" mechanism. Intracellular transferrin levels increase in PD, possibly as a consequence of oxidation of iron-containing prosthetic groups in mitochondria. It is therefore conceivable that transferrin endocytic trafficking can contribute to noxious iron accumulation. This short review will summarize these findings and discuss their relevance for a better understanding of PD pathogenesis.

U2 - 10.1016/j.biocel.2019.02.009

DO - 10.1016/j.biocel.2019.02.009

M3 - Article

C2 - 30818084

VL - 110

SP - 70

EP - 74

JO - International Journal of Biochemistry and Cell Biology

JF - International Journal of Biochemistry and Cell Biology

SN - 1357-2725

ER -